{"DataElement":{"publicId":"13484700","version":"1","preferredName":"Adverse Event Occurrence Type","preferredDefinition":"The unfavorable, unintended consequence associated with a medical treatment, intervention, or procedure.","longName":"13484698v1.00:13484699v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13484698","version":"1","preferredName":"Adverse Event Occurrence","preferredDefinition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).:An instance of something happening, such as an event or incident.","longName":"2235992v1.00:2234856v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2235992","version":"1","preferredName":"Adverse Event","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-74E9-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"FACDF5E8-BC97-74DD-E053-731AD00AB4A1","latestVersionIndicator":"Yes","beginDate":"2023-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-03","modifiedBy":"COLBERTM","dateModified":"2023-05-03","changeDescription":null,"administrativeNotes":"5/3/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13484699","version":"1","preferredName":"Adverse Event Type","preferredDefinition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._Something distinguishable as an identifiable class based on common qualities.","longName":"13484699v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Ototoxicity","valueDescription":null,"ValueMeaning":{"publicId":"13499396","version":"1","preferredName":"Ototoxicity","longName":"13499396v1.00","preferredDefinition":"Damage to the inner ear as a result of exposure to drugs or chemicals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ototoxicity","conceptCode":"C66929","definition":"Damage to the inner ear as a result of exposure to drugs or chemicals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADDFB46-E181-440C-E053-731AD00A68D6","latestVersionIndicator":"Yes","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E184-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Pulmonary Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"13499397","version":"1","preferredName":"Pulmonary Toxicity","longName":"13499397v1.00","preferredDefinition":"Toxicity that impairs or damages the lung(s). This condition is often caused by the administration of a pharmaceutical agent that causes damage to the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Toxicity","conceptCode":"C177374","definition":"Toxicity that impairs or damages the lung(s). This condition is often caused by the administration of a pharmaceutical agent that causes damage to the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADDFB46-E182-440C-E053-731AD00A68D6","latestVersionIndicator":"Yes","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E185-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Rashes","valueDescription":null,"ValueMeaning":{"publicId":"2578055","version":"1","preferredName":"Skin Rash","longName":"2578055","preferredDefinition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Rash","conceptCode":"C39594","definition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDF4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"COOPERM","dateModified":"2017-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E186-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Renal Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"13499398","version":"1","preferredName":"Renal Toxicity","longName":"13499398v1.00","preferredDefinition":"Toxicity that impairs or damages the kidney. This condition is often caused by the administration of a pharmaceutical agent that causes damage to the kidney.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Toxicity","conceptCode":"C115459","definition":"Toxicity that impairs or damages the kidney. This condition is often caused by the administration of a pharmaceutical agent that causes damage to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADDFB46-E183-440C-E053-731AD00A68D6","latestVersionIndicator":"Yes","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E187-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Sinusoidal Obstruction Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2793925","version":"1","preferredName":"Hepatic Veno-Occlusive Disease","longName":"2793925","preferredDefinition":"Blockage of the small- or medium-sized hepatic veins due to nonthrombotic subendothelial edema which may progress to fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinusoidal Obstruction Syndrome","conceptCode":"C26793","definition":"A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594FA4A3-3296-6DA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-10-15","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E188-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Thrombocytopenia","valueDescription":null,"ValueMeaning":{"publicId":"2946035","version":"1","preferredName":"Thrombocytopenia","longName":"2946035","preferredDefinition":"A condition in which there is an abnormally small number of platelets in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D443-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E189-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Typhlitis","valueDescription":null,"ValueMeaning":{"publicId":"2944005","version":"1","preferredName":"Typhlitis","longName":"2944005","preferredDefinition":"Inflammation of the cecum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Typhlitis","conceptCode":"C38043","definition":"Inflammation of the cecum, usually accompanied by neutropenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-1173-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E18A-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E18B-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E18C-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E18D-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Allergic Reaction","valueDescription":null,"ValueMeaning":{"publicId":"7351128","version":"1","preferredName":"Allergic Reaction","longName":"7351128","preferredDefinition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA4C3B35-FE6E-3C61-E053-4EBD850A29C2","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"DWARZEL","dateCreated":"2020-07-13","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E18E-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Cardiac Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"2571817","version":"1","preferredName":"Cardiotoxicity","longName":"2571817","preferredDefinition":"Toxicity that impairs or damages the heart. This condition is often caused by the administration of a pharmaceutical agent that initiates a poisonous or toxic response in cardiac tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiotoxicity","conceptCode":"C27994","definition":"Toxicity that impairs or damages the heart. This condition is often caused by the administration of a pharmaceutical agent that initiates a poisonous or toxic response in cardiac tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E596-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-08","modifiedBy":"CZECHS","dateModified":"2008-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E18F-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Fatigue","valueDescription":null,"ValueMeaning":{"publicId":"4395775","version":"1","preferredName":"Fatigue","longName":"4395775","preferredDefinition":"Overall tiredness and lack of energy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fatigue","conceptCode":"C3036","definition":"Overall tiredness and lack of energy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D9D8-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E190-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Graft Versus Host Disease","valueDescription":null,"ValueMeaning":{"publicId":"2636869","version":"1","preferredName":"Graft Versus Host Disease","longName":"2636869","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FF979BE-A605-6817-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-05-08","modifiedBy":"GDEEN","dateModified":"2023-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E191-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Hemorrhage","valueDescription":null,"ValueMeaning":{"publicId":"4395748","version":"1","preferredName":"Hemorrhage","longName":"4395748","preferredDefinition":"Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D630-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E192-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Hepatic Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"13499395","version":"1","preferredName":"Hepatic Toxicity","longName":"13499395v1.00","preferredDefinition":"Toxicity that impairs or damages the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatic Toxicity","conceptCode":"C185645","definition":"Toxicity that impairs or damages the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADDFB46-E180-440C-E053-731AD00A68D6","latestVersionIndicator":"Yes","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E193-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Hyperbilirubinemia","valueDescription":null,"ValueMeaning":{"publicId":"4395655","version":"1","preferredName":"Hyperbilirubinemia","longName":"4395655","preferredDefinition":"Abnormally high level of bilirubin in the blood. Excess bilirubin is associated with jaundice.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperbilirubinemia","conceptCode":"C27088","definition":"Abnormally high level of bilirubin in the blood. Excess bilirubin is associated with jaundice.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB79BBE-6C13-5F7C-E040-BB89AD435DD5","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E194-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Infection","valueDescription":null,"ValueMeaning":{"publicId":"6610519","version":"1","preferredName":"Infection","longName":"6610519","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F7FD6EF-C887-4DB3-E053-F662850AB340","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E195-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Left Ventricular Systolic Dysfunction","valueDescription":null,"ValueMeaning":{"publicId":"2945404","version":"1","preferredName":"Left Ventricular Systolic Dysfunction","longName":"2945404","preferredDefinition":"An abnormal performance of the left ventricle with an ejection fraction equal to or less than 0.40 (40%).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Left Ventricular Systolic Dysfunction","conceptCode":"C64251","definition":"The degree of impairment of the left cardiac ventricle to contract efficiently. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"745580E8-4803-8FA9-E040-BB89AD433702","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E196-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Mucositis","valueDescription":null,"ValueMeaning":{"publicId":"7492308","version":"1","preferredName":"Mucositis","longName":"7492308","preferredDefinition":"Inflammation of the mucous membranes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucositis","conceptCode":"C115965","definition":"Inflammation of the mucous membranes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36195B7-8A96-2214-E053-4EBD850A71FB","latestVersionIndicator":"Yes","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E197-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Multi Organ Failure","valueDescription":null,"ValueMeaning":{"publicId":"2768995","version":"1","preferredName":"Multiple Organ Failure","longName":"2768995","preferredDefinition":"A progressive condition usually characterized by combined failure of the lungs, liver, kidney, and clotting mechanisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Organ Failure","conceptCode":"C75568","definition":"Complete impairment of two or more organs or organ systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-989F-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E198-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Neuropathy","valueDescription":null,"ValueMeaning":{"publicId":"2751427","version":"1","preferredName":"Neuropathy","longName":"2751427","preferredDefinition":"A disorder affecting the cranial nerves or the peripheral nervous system.  It is manifested with pain, tingling, numbness, and muscle weakness.  It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuropathy","conceptCode":"C4731","definition":"A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC8C1F0-9010-1819-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E199-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Neurotoxicity Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211303","version":"1","preferredName":"Neurotoxicity","longName":"3211303","preferredDefinition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurotoxicity Syndrome","conceptCode":"C27961","definition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EAFB-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E19A-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Neutropenia","valueDescription":null,"ValueMeaning":{"publicId":"4291757","version":"1","preferredName":"Neutropenia","longName":"4291757","preferredDefinition":"A decrease in the number of neutrophils in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutropenia","conceptCode":"C80520","definition":"A decrease in the number of neutrophils in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-63D5-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADDFB46-E19B-440C-E053-731AD00A68D6","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Endocrine Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"13499399","version":"1","preferredName":"Endocrine Therapy Toxicity","longName":"13499399v1.00","preferredDefinition":"Indicates that a toxicity adverse effect has been experienced during endocrine drug treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocrine Therapy Toxicity","conceptCode":"C138163","definition":"Indicates that a toxicity adverse effect has been experienced during endocrine drug treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADE5EA5-6E35-5C83-E053-731AD00A9EED","latestVersionIndicator":"Yes","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADE5EA5-6E39-5C83-E053-731AD00A9EED","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"GI Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"13499400","version":"1","preferredName":"Gastrointestinal Toxicity","longName":"13499400v1.00","preferredDefinition":"Toxicity that impairs or damages the gastrointestinal system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Toxicity","conceptCode":"C185646","definition":"Toxicity that impairs or damages the gastrointestinal system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADE5EA5-6E36-5C83-E053-731AD00A9EED","latestVersionIndicator":"Yes","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADE5EA5-6E3A-5C83-E053-731AD00A9EED","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Musculoskeletal Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"13499401","version":"1","preferredName":"Musculoskeletal Toxicity","longName":"13499401v1.00","preferredDefinition":"A toxicity that impairs or damages the musculoskeletal system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Musculoskeletal Toxicity","conceptCode":"C185647","definition":"A toxicity that impairs or damages the musculoskeletal system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADE5EA5-6E37-5C83-E053-731AD00A9EED","latestVersionIndicator":"Yes","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADE5EA5-6E3B-5C83-E053-731AD00A9EED","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"},{"value":"Psychiatric Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"13499402","version":"1","preferredName":"Toxicity due to Psychiatric Drugs","longName":"13499402v1.00","preferredDefinition":"Toxicity that develops due to the administration of psychiatric medications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity due to Psychiatric Drugs","conceptCode":"C185648","definition":"Toxicity that develops due to the administration of psychiatric medications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADE5EA5-6E38-5C83-E053-731AD00A9EED","latestVersionIndicator":"Yes","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FADE5EA5-6E3C-5C83-E053-731AD00A9EED","beginDate":"2023-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2739026","version":"1","preferredName":"Adverse Event Type","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.:Type; a subdivision of a particular kind of thing.","longName":"C41331:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A10AF04-DD16-45CE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-04","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-04","modifiedBy":"ONEDATA","dateModified":"2008-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"FACE1FB1-3DDD-7A31-E053-731AD00A8671","latestVersionIndicator":"Yes","beginDate":"2023-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-03","modifiedBy":"KUMMEROA","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":"2023.5.4 PVs added to PV per MR. ak 5/3/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173218","version":"1","longName":"Adverse Events","context":"Pediatric Cancer"},{"publicId":"12173181","version":"1","longName":"Events","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"ADVERSE_EVENT","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Data Element Adverse Event Occurrence Adverse Event Type does not have Preferred Question Text.","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"FACE4F52-D471-052E-E053-731AD00ADA14","latestVersionIndicator":"Yes","beginDate":"2023-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-03","modifiedBy":"COLBERTM","dateModified":"2023-05-03","changeDescription":null,"administrativeNotes":"5/3/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"}}